PHILADELPHIA – An investigational 5-HT6 inhibitor in combination with donepezil significantly boosted cognition in patients with moderate Alzheimer’s disease and has advanced into three...

Field of Interest: Geriatrics

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness